Acute Catheterization and Urgent Intervention Triage Strategy Trial - PCI Subgroup: 30-Day and 1-Year Results - ACUITY PCI: 30-day and 1-Year Results


The goal of the substudy was to evaluate treatment with heparin plus glycoprotein (GP) IIb/IIIa inhibition compared with bivalirudin with or without GP IIb/IIIa inhibition among patients with acute coronary syndromes (ACS) undergoing percutaneous coronary intervention (PCI).